Received Jan 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Painful shots; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Painful shots). The outcome of the pain was not reported. It was unknown if the reporter considered the pain to be related to Shingles vaccine. It was unknown if the company considered the pain to be related to Shingles vaccine. Additional Information: GSK receipt date: 11-JAN-2026 This case was reported by a patient via interactive digital media. The patient stated that the two shingles vaccine doses were among the most painful injections the patient had ever received. The patient acknowledged that receiving the vaccination was still preferable to the alternative of contracting shingles. The batch number was not provided, and we are unable to contact the reporter. For tolerance of 2nd dose of Shingles vaccine, refer case US2026AMR005217.; Sender's Comments: US-GSK-US2026AMR005217:Case for 2nd dose